The roles of ERAP1 and ERAP2 in autoimmunity and cancer immunity: new insights and perspective
Autoimmunity and cancer affect millions worldwide and both, in principal, result from dysregulated immune responses. There are many well-known molecules involved in immunological process playing as a double-edged sword, by which associating autoimmune diseases and cancer. In this regard, Endoplasmic...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2 March 2020
|
| In: |
Molecular immunology
Year: 2020, Jahrgang: 121, Pages: 7-19 |
| ISSN: | 1872-9142 |
| DOI: | 10.1016/j.molimm.2020.02.020 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.molimm.2020.02.020
|
| Verfasserangaben: | Farhad Babaie, Ramin Hosseinzadeh, Mehrdad Ebrazeh, Narges Seyfizadeh, Saeed Aslani, Soraya Salimi, Maryam Hemmatzadeh, Gholamreza Azizi, Farhad Jadidi-Niaragh, Hamed Mohammadi |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1724118358 | ||
| 003 | DE-627 | ||
| 005 | 20230426081756.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200709s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.molimm.2020.02.020 |2 doi | |
| 035 | |a (DE-627)1724118358 | ||
| 035 | |a (DE-599)KXP1724118358 | ||
| 035 | |a (OCoLC)1341344766 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Babaie, Farhad |e VerfasserIn |0 (DE-588)1213482690 |0 (DE-627)1724119346 |4 aut | |
| 245 | 1 | 4 | |a The roles of ERAP1 and ERAP2 in autoimmunity and cancer immunity |b new insights and perspective |c Farhad Babaie, Ramin Hosseinzadeh, Mehrdad Ebrazeh, Narges Seyfizadeh, Saeed Aslani, Soraya Salimi, Maryam Hemmatzadeh, Gholamreza Azizi, Farhad Jadidi-Niaragh, Hamed Mohammadi |
| 264 | 1 | |c 2 March 2020 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.07.2020 | ||
| 520 | |a Autoimmunity and cancer affect millions worldwide and both, in principal, result from dysregulated immune responses. There are many well-known molecules involved in immunological process playing as a double-edged sword, by which associating autoimmune diseases and cancer. In this regard, Endoplasmic reticulum aminopeptidases (ERAP) 1, which belongs to the M1 family of aminopeptidases, plays a central role as a "molecular ruler", proteolyzing of N-terminal of the antigenic peptides before their loading onto HLA-I molecules for antigen presentation in the Endoplasmic Reticulum (ER). Several genome-wide association studies (GWAS) highlighted the significance of ERAP1 and ERAP2 in autoimmune diseases, including Ankylosing spondylitis, Psoriasis, Bechet's disease, and Birdshot chorioretinopathy, as well as in cancers. The expression of ERAP1/2 is mostly altered in different cancers compared to normal cells, but how this affects anti-cancer immune responses and cancer growth has been little explored. Recent studies on the immunological outcomes and the catalytic functions of ERAP1 and ERAP2 have provided a better understanding of their potential pathogenetic role in autoimmunity and cancer. In this review, we summarize the role of ERAP1 and ERAP2 in the autoimmune diseases and cancer immunity based on the recent advances in GWAS studies. | ||
| 650 | 4 | |a ankylosing-spondylitis susceptibility | |
| 650 | 4 | |a antigen-processing machinery | |
| 650 | 4 | |a Autoimmunity | |
| 650 | 4 | |a behcets-disease | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Endoplasmic reticulum aminopeptidases | |
| 650 | 4 | |a genome-wide association | |
| 650 | 4 | |a hla class-i | |
| 650 | 4 | |a leucine aminopeptidase | |
| 650 | 4 | |a leucyl-specific aminopeptidase | |
| 650 | 4 | |a mhc class-i | |
| 650 | 4 | |a reticulum aminopeptidase 1 | |
| 650 | 4 | |a Single nucleotide polymorphism | |
| 650 | 4 | |a single nucleotide polymorphism | |
| 700 | 1 | |a Hosseinzadeh, Ramin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ebrazeh, Mehrdad |e VerfasserIn |4 aut | |
| 700 | 1 | |a Seyfizadeh, Narges |e VerfasserIn |0 (DE-588)1181446643 |0 (DE-627)166266995X |4 aut | |
| 700 | 1 | |a Aslani, Saeed |e VerfasserIn |4 aut | |
| 700 | 1 | |a Salimi, Soraya |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hemmatzadeh, Maryam |e VerfasserIn |4 aut | |
| 700 | 1 | |a Azizi, Gholamreza |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jadidi-Niaragh, Farhad |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mohammadi, Hamed |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular immunology |d Amsterdam [u.a.] : Elsevier, 1979 |g 121(2020), Seite 7-19 |h Online-Ressource |w (DE-627)320511332 |w (DE-600)2013448-4 |w (DE-576)252776437 |x 1872-9142 |7 nnas |a The roles of ERAP1 and ERAP2 in autoimmunity and cancer immunity new insights and perspective |
| 773 | 1 | 8 | |g volume:121 |g year:2020 |g pages:7-19 |g extent:13 |a The roles of ERAP1 and ERAP2 in autoimmunity and cancer immunity new insights and perspective |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.molimm.2020.02.020 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200709 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 1181446643 |a Seyfizadeh, Narges |m 1181446643:Seyfizadeh, Narges |d 910000 |e 910000PS1181446643 |k 0/910000/ |p 4 | ||
| 999 | |a KXP-PPN1724118358 |e 3722714990 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Farhad Babaie, Ramin Hosseinzadeh, Mehrdad Ebrazeh, Narges Seyfizadeh, Saeed Aslani, Soraya Salimi, Maryam Hemmatzadeh, Gholamreza Azizi, Farhad Jadidi-Niaragh, Hamed Mohammadi"]},"id":{"eki":["1724118358"],"doi":["10.1016/j.molimm.2020.02.020"]},"origin":[{"dateIssuedDisp":"2 March 2020","dateIssuedKey":"2020"}],"relHost":[{"title":[{"title":"Molecular immunology","title_sort":"Molecular immunology"}],"recId":"320511332","language":["eng"],"disp":"The roles of ERAP1 and ERAP2 in autoimmunity and cancer immunity new insights and perspectiveMolecular immunology","note":["Gesehen am 16.01.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"extent":"13","volume":"121","text":"121(2020), Seite 7-19","pages":"7-19","year":"2020"},"pubHistory":["16.1979 -"],"id":{"issn":["1872-9142"],"eki":["320511332"],"zdb":["2013448-4"]},"origin":[{"publisher":"Elsevier ; Pergamon Press","dateIssuedKey":"1979","dateIssuedDisp":"1979-","publisherPlace":"Amsterdam [u.a.] ; Oxford ; Frankfurt, M. [u.a.]"}],"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"13 S."}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Babaie, Farhad","given":"Farhad","family":"Babaie"},{"role":"aut","display":"Hosseinzadeh, Ramin","roleDisplay":"VerfasserIn","given":"Ramin","family":"Hosseinzadeh"},{"given":"Mehrdad","family":"Ebrazeh","role":"aut","display":"Ebrazeh, Mehrdad","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Seyfizadeh, Narges","roleDisplay":"VerfasserIn","given":"Narges","family":"Seyfizadeh"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Aslani, Saeed","given":"Saeed","family":"Aslani"},{"display":"Salimi, Soraya","roleDisplay":"VerfasserIn","role":"aut","family":"Salimi","given":"Soraya"},{"family":"Hemmatzadeh","given":"Maryam","display":"Hemmatzadeh, Maryam","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Gholamreza","family":"Azizi","role":"aut","roleDisplay":"VerfasserIn","display":"Azizi, Gholamreza"},{"family":"Jadidi-Niaragh","given":"Farhad","roleDisplay":"VerfasserIn","display":"Jadidi-Niaragh, Farhad","role":"aut"},{"role":"aut","display":"Mohammadi, Hamed","roleDisplay":"VerfasserIn","given":"Hamed","family":"Mohammadi"}],"title":[{"title_sort":"roles of ERAP1 and ERAP2 in autoimmunity and cancer immunity","title":"The roles of ERAP1 and ERAP2 in autoimmunity and cancer immunity","subtitle":"new insights and perspective"}],"language":["eng"],"recId":"1724118358","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 09.07.2020"]} | ||
| SRT | |a BABAIEFARHROLESOFERA2202 | ||